Engineering TAG-72 and CD30 CAR-T Cells for T Cell Malignancies
{{output}}
Background: T cell malignancies represent a broad, highly heterogeneous subset of lymphomas with poor prognosis. Chimeric antigen receptor (CAR)-T cell therapy holds great promise in treating B cell lymphoma and multiple myeloma.... ...
